Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Le Havre

35 clinical trials in Le Havre, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Le Havre at a glance
35
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

35 trials in Le Havre

Open in trial search

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ivonescimab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study on the Safety and Effectiveness of Short Dual Antiplatelet Therapy with Ticagrelor, Clopidogrel, and Prasugrel in Patients Aged 65+ with Coronary Artery Disease

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Clopidogrel
  • Sponsor:Centre Hospitalier Universitaire De Caen Normandie

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Unicancer

Study on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Pyoderma

Recruiting

Study on Short vs. Standard Amoxicillin Treatment for Adults with Lower Limb Erysipelas

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Assistance Publique Hopitaux De Paris

Rectal cancer+2

Recruiting

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Polycythaemia vera+4

Recruiting

Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Asthma

Recruiting

Study on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on the Effect of Domperidone on Blood Sugar Control in Type 1 Diabetes Patients with Delayed Stomach Emptying

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Domperidone
  • Sponsor:Centre Hospitalier Universitaire Rouen

Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Assistance Publique Hopitaux De Paris

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Le Havre

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on head and neck cancers and multiple myeloma, testing new therapeutic combinations and treatment strategies.

  • Advanced squamous cell carcinoma treatments
  • Multiple myeloma therapies
  • Brain metastases management

Studies evaluating novel immunotherapy combinations and targeted treatments for various cancer types.

02 Cardiovascular Studies

Research examining antiplatelet therapy approaches and treatments for various cardiovascular conditions in elderly patients.

  • Coronary interventions
  • Stroke prevention
  • Vascular disease management

Investigations into optimizing treatment durations and combinations for better patient outcomes.

03 Autoimmune Conditions

Clinical trials evaluating treatments for Sjögren's syndrome and lupus erythematosus, focusing on innovative therapeutic approaches.

  • Severe asthma treatments
  • Cutaneous lupus management
  • Inflammatory disease therapies

Studies aimed at improving disease control and patient quality of life.

04 Infectious Diseases

Research on urinary tract infections and innovative antibiotic treatments, including studies on optimal treatment durations.

  • Bacterial infection management
  • Antibiotic therapy optimization
  • Septic shock treatments

Investigations focusing on improving treatment efficacy and patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.